Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LABCORP HOLDINGS INC.
Report date April 01, 2019 · Filed April 03, 2019
Section 16 reporting ended · disclosed 2019-04-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,662.9335 |
Ending reported balance
After 2019-04-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-04-01 · Grant · Acquired 5,530 · Balance 15,441.9335 F1: Shares acquired on April 1, 2019, pursuant to a performance award granted on February 9, 2016, relating to performance during the three-year period ended December 31, 2018. Row 2 · 2019-04-01 · Tax withholding · Disposed 1,779 · Balance 13,662.9335 F2: Stock withholding to satisfy tax withholding obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired on April 1, 2019, pursuant to a performance award granted on February 9, 2016, relating to performance during the three-year period ended December 31, 2018.
F2: Stock withholding to satisfy tax withholding obligations.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2019 Filed Apr 3, 2019 21:24 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 1,779 | $154.79 | $275,371.41 |
DisclosureSEC source: 0001127602-19-014718 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,662.9335 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:24 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantCommon Stock | 5,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-014718 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,441.9335 F1 · kind: Shares acquired on April 1, 2019, pursuant to a performance award granted on February 9, 2016, relating to performance during the three-year period ended December 31, 2018. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:13 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 196 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005993 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641 Underlying: Common Stock · 196 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:13 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 54 | $146.59 | $7,915.86 |
DisclosureSEC source: 0001127602-19-005993 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,911.9335 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:13 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 196 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005993 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,965.9335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:18 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005562 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:18 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 124 | $144.29 | $17,891.96 |
DisclosureSEC source: 0001127602-19-005562 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,769.9335 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:18 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005562 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,893.9335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:48 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005191 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,287 Underlying: Common Stock · 247 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:48 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 68 | $147.46 | $10,027.28 |
DisclosureSEC source: 0001127602-19-005191 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,443.9335 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 122.8283 shares acquired on June 29, 2018 and 29.1161 shares acquired on December 31, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:48 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 247 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005191 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,511.9335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 122.8283 shares acquired on June 29, 2018 and 29.1161 shares acquired on December 31, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 15:11 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionNon-qualified Stock Options · Derivative | 13,000 | $0.00 Strike: $84.86 | $0.00 |
DisclosureSEC source: 0001127602-18-020440 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,000 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan. F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on 5/24/13 and is now fully exercisable. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 15:11 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 13,000 | $183.35 | $2,383,557.80 |
DisclosureSEC source: 0001127602-18-020440 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,112.9891 F1 · price: The price of $183.3506 per share represents a weighted average of sales prices ranging from $182.97 to $183.84 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 15:11 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 13,000 | $84.86 | $1,103,180.00 |
DisclosureSEC source: 0001127602-18-020440 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,112.9891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:53 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 1,600 | $161.75 | $258,800.00 |
DisclosureSEC source: 0001127602-18-013182 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,112.9891 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:53 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantCommon Stock | 4,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013182 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,712.9891 F1 · kind: Shares acquired on March 29, 2018, pursuant to a performance award granted on March 11, 2015, relating to performance during the three-year period ended December 31, 2017. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:12 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-011543 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,534 Underlying: Common Stock · 400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 3/11/2016 and are now fully vested. F4 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 3/11/2016 and are now fully vested. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:12 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 111 | $175.61 | $19,492.71 |
DisclosureSEC source: 0001127602-18-011543 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,860.9891 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 24 and 42 shares that were inadvertently omitted from the reporting person's original Forms 4 filed on April 9, 2018 and April 13, 2018, respectively, due to a clerical error. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:12 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-011543 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,971.9891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 24 and 42 shares that were inadvertently omitted from the reporting person's original Forms 4 filed on April 9, 2018 and April 13, 2018, respectively, due to a clerical error. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 19:24 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005992 · form4.xml · derivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,934 Underlying: Common Stock · 590 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/19. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/19. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 19:24 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantNon-qualified Stock Options · Derivative | 2,300 | $0.00 Strike: $168.49 | $0.00 |
DisclosureSEC source: 0001127602-18-005992 · form4.xml · derivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Underlying: Common Stock · 2,300 shares Expires 2028-02-11 F1 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal installments beginning on the date reflected in this column. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:51 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005408 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,344 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/2017. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:51 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 167 | $168.08 | $28,069.36 |
DisclosureSEC source: 0001127602-18-005408 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,505.9891 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 18:51 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-005408 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,672.9891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:01 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004901 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,794 Underlying: Common Stock · 246 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:01 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 92 | $169.66 | $15,608.72 |
DisclosureSEC source: 0001127602-18-004901 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,222.9891 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 37.8767 shares acquired on December 31, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:01 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 246 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004901 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,314.9891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 37.8767 shares acquired on December 31, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:35 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 2,671 | $160.13 | $427,713.91 |
DisclosureSEC source: 0001127602-17-024876 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,031.1124 F1 · balance_after: Amount includes 148.5275 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:35 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 200 | $160.13 | $32,025.00 |
DisclosureSEC source: 0001127602-17-024876 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,702.1124 F1 · balance_after: Amount includes 148.5275 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:49 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 2,850 | $143.19 | $408,091.50 |
DisclosureSEC source: 0001127602-17-013373 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,753.5849 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:49 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantCommon Stock | 6,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013373 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,603.5849 F1 · kind: Shares acquired on March 29, 2017, pursuant to a performance award granted on February 11, 2014, relating to performance during the three-year period ended December 31, 2016. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 18:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 149 | $144.24 | $21,491.76 |
DisclosureSEC source: 0001127602-17-011537 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,848.5849 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011537 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,040 Underlying: Common Stock · 400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/16. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 3/11/16. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 11, 2017 Filed Mar 14, 2017 18:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-011537 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,997.5849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 22:45 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 182 | $134.93 | $24,557.26 |
DisclosureSEC source: 0001127602-17-006082 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,597.5849 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2017 Filed Feb 14, 2017 22:45 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-006082 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,440 Underlying: Common Stock · 550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/11/15 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/11/15 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2017 Filed Feb 14, 2017 22:45 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006082 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,779.5849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 19:31 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005329 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,990 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/17. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/9/17. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 19:31 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 138 | $133.83 | $18,468.54 |
DisclosureSEC source: 0001127602-17-005329 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,229.5849 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 155.1793 shares acquired on June 30, 2016 under the Laboratory Corporation of America Holdings 1997 Employee Stock Purchase Plan and 45.841 shares acquired on December 31, 2016 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 19:31 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-005329 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,367.5849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 155.1793 shares acquired on June 30, 2016 under the Laboratory Corporation of America Holdings 1997 Employee Stock Purchase Plan and 45.841 shares acquired on December 31, 2016 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2017 Filed Feb 9, 2017 19:41 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantNon-qualified Stock Options · Derivative | 2,800 | $0.00 Strike: $130.60 | $0.00 |
DisclosureSEC source: 0001127602-17-004730 · form4.xml · derivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 Underlying: Common Stock · 2,800 shares Expires 2027-02-06 F4 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F5 · derivative.exercise_date: The option vests in three equal installments beginning on the date reflected in this column. Read SEC document |
| February 07, 2017 Filed Feb 9, 2017 19:41 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 740 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-004730 · form4.xml · derivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,440 Underlying: Common Stock · 740 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F2 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.